Press Releases

Cosmofarma Exhibition 2015, the leading event for the pharmacy world organized by Bologna Fiere and held in Bologna from 17 to 19 April, offers companies the most functional business opportunities with major national and international distributors. To encourage networking...

80% of the finalists for the ‘Most Valuable Patient Initiative’ Categoryof the 2015 eyeforpharma Philadelphia Awards are focussing on education as a means of engaging with andimproving the lives of patients. Projects from Novartis and...

eyeforpharma, London (January, 19, 2015): According to LEO Pharma, Ipsen and Grünenthaldriving patient-centric leadership has become priority as the patient voice shapes the future for the pharmaceutical industry. Speaking ahead...

This appointment will allow him to drive developments at CiToxLAB’s European and North American sites in the area of preclinical and clinical biomarkers, which is currently experiencing strong growth CiToxLAB, a leading CRO for non-clinical research,...

Richard Bergström, Director General, EFPIA argued passionately in favour of the homogenisation of European HTA bodies and regulation, during a recent interview with Paul Simms, Chairman, eyeforpharma. Asserting that harmonisation would be the only way for market access to...

US-based Eli Lilly and Company has completed the acquisition of Novartis Animal Health for $5.4bn. Lilly noted the acquisition was funded with $3.4bn cash-on-hand and $2bn in debt.The deal was first announced at the end of...

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today a further enhancement to the development of its lead...